Browsing by Author Oliveira, Mafalda
Showing results 1 to 7 of 7
Issue Date | Title | Author(s) |
---|---|---|
6-Mar-2024 | Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy | Pascual, Tomás; Fernández Martínez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic Ruché, Núria; Brasó Maristany, Fara; Gonzàlez-farré, Blanca; Paré, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Muñoz, Montserrat; Galván, Patricia; Gonzàlez Farré, Xavier; Oliveira, Mafalda; Gil Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavilá, Joaquín; Prat Aparicio, Aleix; Perou, Charles M. |
7-Sep-2022 | High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancer | Palafox Sánchez, Marta; Monserrat Vicente, Laia; Bellet Ezquerra, Meritxell; Villacampa, Gullermo; González Pérez, Abel; Oliveira, Mafalda; Brasó Maristany, Fara; Ibrahimi, Nusaibah; Kannan, Srinivasaraghavan; Mina, Leonardo; Herrera Abreu, Maria Teresa; Odena, Andreu; Sánchez Guixé, Mònica; Capelán, Marta; Azaro, Analía; Bruna, Alejandra; Rodriguez, Olga; Guzmán, Marta; Grueso, Judit; Viaplana, Cristina; Hernandez, Javier; Su, Faye; Lin, Kui; Clarke, Robert; Caldas, Carlos; Arribas, Joaquín; Michiels, Stefan; García Sanz, Alicia; Turner, Nicholas, 1951-; Prat Aparicio, Aleix; Nuciforo, Paolo; Dienstmann, Rodrigo; Verma, Chandra S; López Bigas, Núria; Scaltriti, Maurizio; Arnedos, Monica; Saura, Cristina; Serra Elizalde, Violeta |
28-Apr-2023 | HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer | Olivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás |
19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
9-Jan-2019 | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial | Gavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |